They Strategy to complete this next phase III research by the end of the 12 months. Once the stage III is complete, MAPS will submit an application for FDA approval for MDMA therapy. They foresee FDA approval to come in late 2023. As soon as it can be authorized, the https://droguerieviral.com/product-tag/anfetamina-liquida-in-vendita/